Monthly Archives: April 2014
This was published just yesterday: Gilead Profit Triples, Hepatitis C Drug Revenue Reaches $2.3B http://www.foxbusiness.com/industries/2014/04/22/gilead-profit-triples-hepatitis-c-drug-revenue-reaches-23b/ Admiration to Henry Waxman (House of representatives) asking Gilead to explain the pricing of the drug!
Yesterday, April 10th, we had an inspiring and motivating call with Rachel Kiddell-Monroe. She has agreed to be our “Drug Bio Advisor”, saying she thinks the project is extremely important for UAEM’s advocacy work! She said that finding information for the drug bios is challenging and that a bit of detective work will be required […]